Chronic Stable Angina

3
Pipeline Programs
1
Companies
1
Clinical Trials
1
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
3
Early DiscoveryClinical DevelopmentMarket

On Market (1)

Approved therapies currently available

U
ASPRUZYO SPRINKLEApproved
ranolazine
Unknown Company
Anti-anginal [EPC]oral2022

Competitive Landscape

1 companies ranked by most advanced pipeline stage

GS
Gilead SciencesFOSTER CITY, CA
2 programs
2
ranolazinePhase 41 trial
ranolazinePhase 4
Active Trials
NCT01558830Unknown50Est. Jul 2013

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Gilead Sciencesranolazine

Clinical Trials (1)

Total enrollment: 50 patients across 1 trials

Safety of Amiodarone and Ranolazine Together in Patients With Angina

Start: Jan 2012Est. completion: Jul 201350 patients
Phase 4Unknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space